Showing results (201-210 of 285) with videos related to
Sort By:
Pageof 29
Skin Pharmacology and Applied Skin Physiology|October 13, 2001
Chemoprevention of skin cancer through natural agentsS Gupta, H MukhtarSkin Pharmacology and Applied Skin Physiology|October 13, 2001
New developments in photoprotection of human skinJ KrutmannSkin Pharmacology and Applied Skin Physiology|October 5, 2001
Perforin granule release from cytotoxic lymphocytes ex vivo is inhibited by ciclosporin but not by methotrexateA Ambach, B Bonnekoh, H GollnickSkin Pharmacology and Applied Skin Physiology|July 21, 2001
Distribution of hydrolytic activity catalyzes the biotransformation of prednisolone 21-acetate in human skinT Hikima, H I MaibachSkin Pharmacology and Applied Skin Physiology|March 15, 2003
The topical treatment of psoriasisP C M van de Kerkhof, W H P M VissersSkin Pharmacology and Applied Skin Physiology|March 15, 2003
Anti-acne effects of Oriental herb extracts: a novel screening method to select anti-acne agentsC Nam, S Kim, Y Sim, et al.Skin Pharmacology and Applied Skin Physiology|March 15, 2003
In vitro and in vivo study of 5-methoxypsoralen skin concentration after topical applicationG Colombo, A Zucchi, F Allegra, et al.Skin Pharmacology and Applied Skin Physiology|December 12, 2002
Permeation and skin absorption: reproducibility of various industrial reconstructed human skin modelsC Lotte, C Patouillet, M Zanini, et al.Skin Pharmacology and Applied Skin Physiology|December 12, 2002
Improvement of the experimental setup to assess cutaneous bioavailability on human skin models: dynamic protocolF Dreher, C Patouillet, F Fouchard, et al.Skin Pharmacology and Applied Skin Physiology|December 12, 2002
Comparison of cutaneous bioavailability of cosmetic preparations containing caffeine or alpha-tocopherol applied on human skin models or human skin ex vivo at finite dosesFrank Dreher, Frédéric Fouchard, Claire Patouillet, et al.Pageof 29